BioSpace News Archive

Drug Development

Conatus Pharma Clinical Results At EASL Meeting Support Emricasan Registration Pathway In NASH

April 23, 2015
·
8 min read
Bio NC

Argos Therapeutics, Inc. Recognized For Economic Development At The 17th Annual Triangle CREW Champion Awards

April 23, 2015
·
4 min read
Drug Development

Merck & Co. Announces Results From Phase 2/3 Study Of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir In Patients With Advanced Chronic Kidney Disease

April 23, 2015
·
9 min read
Drug Development

Medivir AB: Data From OPTIMIST Trials Show SVR12 Rates Of 97 Percent In HCV Patients Without Cirrhosis And 84 Percent In HCV Patients With Cirrhosis

April 23, 2015
·
4 min read
Drug Development

Gilead’s Harvoni And Sovaldi Demonstrate Efficacy And Safety Among Chronic Hepatitis C Patients With Advanced Liver Disease

April 23, 2015
·
10 min read
Business

RegenRx And Dimension Therapeutics Add Development Of Treatments For Two Metabolic Diseases To Exclusive License Agreement

April 23, 2015
·
2 min read
Drug Development

Merck & Co. Touts Results From C-SURFER Phase II/III Clinical Trial

April 23, 2015
·
9 min read
Biotech Bay

South San Francisco’s Veracyte, Inc. Brings In $40 Million

April 23, 2015
·
5 min read
Drug Development

AuraSense Therapeutics Announces Publication Of Preclinical Data Demonstrating Immuno-Modulation By Its Proprietary Spherical Nucleic Acid Platform

April 23, 2015
·
2 min read
Bio NC

SCYNEXIS, Inc. Announces Pricing Of Public Offering Of Common Stock

April 23, 2015
·
2 min read